Member Log in


hinari-ad2.gif
 

Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women

(Eurekalert) 23 May 2010: Pregnancy doubles HIV risk in men; first trial of a microbicide in pregnant women. Young women of reproductive-age are among those at greatest risk of acquiring HIV, and several studies have suggested that during pregnancy women are even more susceptible to infection.

  • Posted by Neville
  • Published: 2010-05-23

Vaginal gel with integrase inhibitor shows promise in monkeys

(Eurekalert) 23 May 2010: Vaginal gel with integrase inhibitor shows promise in monkeys. Researchers testing a vaginal microbicide based on a new type of anti-HIV drug found it provided monkeys significant protection against infection with a virus similar to HIV, according to a study reported at the International Microbicides Conference in Pittsburgh today.

  • Posted by Neville
  • Published: 2010-05-23

Times Live Blog: M2010 Microbicides: HIV prevention conference opens tonight

by Claire Keeton (23 May 2010): The use of ARVs in microbicides to prevent HIV, rectal microbicides, the risks of getting HIV during pregnancy and anal sex, and new formulations like films and vaginal rings are “hot topics” for M2010, according to the co-chairman Dr Ian McGowan.

  • Posted by hannes
  • Published: 2010-05-23

Vaginal gel shows promise in monkeys

By Henry Neondo (ASNS) 23 May 2010: Researchers testing a vaginal microbicide based on a new type of anti-HIV drug found it provided monkeys significant protection against simian/human immunodeficiency virus (SHIV) – a combination of HIV and a related monkey virus, a virus similar to HIV, according to a study reported at the International Microbicides Conference in Pittsburgh, Sunday.

  • Posted by Karel
  • Published: 2010-05-23

Where was the polio vaccine discovered?

By Claire Keeton (Times Live Blog) 23 May 2010: Pittsburgh, the host city of the M2010 Microbicides conference this week, is also the city where Jonas Salk developed the polio vaccine.

  • Posted by Karel
  • Published: 2010-05-23

South African activist wants microbicides field opened up

By Henry Neondo (ASNS) 23 May 2010: Outside advances in science, activism could correctly be said to have been the single most major contributor to the successes, development and wide accessibility of Anti-retroviral drugs that have helped in the management of HIV.

  • Posted by Karel
  • Published: 2010-05-23

Women like using anti-HIV microbicide gels during sex

By Claire Keeton (Times Live Blog) 23 May 2010: Microbicide gels are acceptable to most women during sex, the results of three studies presented today at the M2010 Microbicides conference showed.

  • Posted by Karel
  • Published: 2010-05-23

State of the ART of microbicides

By Bobby Ramakant (Citizen-News, The Zimbabwe Telegraph, Healthdev.net) 23 May 2010: The microbicides field has undoubtedly moved and shifted a lot in the past decade. Now, with first generation microbicides candidate products up and gone, antiretroviral treatment (ART)-drug based microbicides in spotlight, and only three major microbicides efficacy studies remaining, the need to lobby for increased funding of microbicides research and development, was never so compelling.

  • Posted by Karel
  • Published: 2010-05-23

M2010 Microbicides: HIV prevention conference opens tonight

By Claire Keeton (Times Live Blog) 23 May 2010: The use of ARVs in microbicides to prevent HIV, rectal microbicides, the risks of getting HIV during pregnancy and anal sex, and new formulations like films and vaginal rings are “hot topics” for M2010, according to the co-chairman Dr Ian McGowan.

  • Posted by Karel
  • Published: 2010-05-23

HIV researchers congregate in the US

By Tsitsi Jonas (The Standard) 23 May 2010: Zimbabwean researchers will this week join experts from the rest of the world searching for more effective HIV prevention methods at the International Microbicides Conference in Pittsburgh, United States.

  • Posted by Karel
  • Published: 2010-05-23

New Report outlines the growing field of Rectal Microbicide R&D

(Eurekalert) 19 May 2010: International Rectal Microbicide Advocates release update on new HIV prevention technology: New report outlines the growing field of rectal microbicide R&D

  • Posted by Neville
  • Published: 2010-05-19

AP: Latest attempt to block HIV: Stronger vaginal gels

By Lauran Neergaard (Associated Press) 17 May 2010: Try after try to make vaginal creams that could repel the AIDS virus have failed. Now researchers are testing if a drug used to treat HIV infection finally might give women a tool to prevent it-by infusing the medicine into vaginal gels and contraceptive-style rings.

  • Posted by Neville
  • Published: 2010-05-17

STATEMENT: HIV prevention research focus of International Microbicides Conference May 22-25

(Eurekalert!, Pittsburgh, PA) 14 April 14 2010: HIV prevention researchers, policy makers and community advocates from more than 35 countries will be in Pittsburgh, May 22-25 to attend the 2010 International Microbicides Conference (M2010).

  • Posted by Karel
  • Published: 2010-04-14

Microbicides, vaccines may need to repel HIV contact at mucosa

Keith Alcorn (Aidsmap) 9 April 2010: HIV can damage the walls of cells in the mucous membranes in the genital tract and the intestines, permitting the virus to pass across these barriers and infect vulnerable cells below, even when the tissue is undamaged, Canadian researchers report this week in the journal PLoS Pathogens.

  • Posted by Karel
  • Published: 2010-04-09

More clues emerge on how HIV infects women (Business Week)

Virus can invade after breaking down the protective barrier in women's reproductive tract, study finds. Researchers have identified a previously unknown way that women are infected with HIV, the virus that causes AIDS.

  • Posted by Karel
  • Published: 2010-04-08
« Previous 15 items Next 15 items » 1 2 3 [4] 5 6 7 ... 13